Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications-Reference-Cited by-同舟云学术

Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications

Published:2019-05-31 Issue:2 Volume:50 Page:144-158
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Jayakumar Saumya¹,Loomba Rohit¹²^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine; NAFLD Research Center, University of California at San Diego; La Jolla California

2. Division of Epidemiology, Department of Family Medicine and Public Health; University of California at San Diego; La Jolla California

Funder

Salix Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15314/fullpdf

Reference175 articles.

1. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO);J Hepatol,2016

2. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals;Masuoka;Ann N Y Acad Sci,2013

3. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994;Lazo;Am J Epidemiol,2013

4. NAFLD and liver transplantation: current burden and expected challenges;Pais;J Hepatol,2016

5. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome;AMB Express;2024-08-02

2. Gut Dysbiosis is Associated With the Severity of Liver Fibrosis Assessed by Magnetic Resonance Elastography in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease;EMJ Hepatology;2024-07-18

3. Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD;Nutrients;2024-06-07

4. Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights;International Journal of Molecular Sciences;2024-04-30

5. The gut-liver axis in fatty liver disease: role played by natural products;Frontiers in Pharmacology;2024-04-15